Dr. Lewis Roberts, MD

• Gastroenterology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Mayo Clinic Alix School Of Medicine

  Fellowship Hospital, 1998

• 4566 The Impact of Migration on Viral Hepatitis Prevalence and Elimination Among 30 European Nations: A modeling approach, 2020-06-01

• RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?, 2022-05-04

• Development and Preliminary Testing of a Translational Model of Hepatocellular Carcinoma for Magnetic Resonance Imaging and Interventional Oncologic Investigations, 2012-01-20

• Liver Stiffness Measurement by Magnetic Resonance Elastography is not associated with Developing Hepatocellular Carcinoma in Subjects with Compensated Cirrhosis, 2011-05-03

• Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma, 2012-12-05

• Heat stress induced cell death mechanisms in hepatocytes and hepatocellular carcinoma:in vitroandin vivostudy, 2014-03-18

• Decreased Expression of Sulfatase 2 in the Brains of Alzheimer's Disease Patients: Implications for Regulation of Neuronal Cell Signaling, 2017-09-28

• 54443 Pharmacogenomic Profiling of East and West African Populations, 2021-03-30

• Ambulatory end-stage liver disease in Ghana; patient profile and utility of alpha fetoprotein and aspartate aminotransferase: platelet ratio index, 2020-12-26

• Alpha-fetoprotein, Des-gamma Carboxyprothrombin, and Lectin-Bound Alpha-fetoprotein in Early Hepatocellular Carcinoma, 2009-04-09

• A new HIF-1a/RANTES driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF, 2016-03-07

• Mutations inIsocitrate Dehydrogenase 1and2Occur Frequently in Intrahepatic Cholangiocarcinomas and Share Hypermethylation Targets with Glioblastomas, 2012-07-23

• Effect of Statins on the Risk of Extrahepatic Cholangiocarcinoma, 2020-10-09

• Molecular bioluminescence imaging as a non-invasive tool for monitoring tumor growth and therapeutic response to MRI-guided laser ablation in a rat model of hepatocellular carcinoma, 2014-01-21

• Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy, 2021-03-26

• Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma, 2019-09-01

• Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma, 2023-03-06

• Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein, 2016-05-20

• DNA Methylation of Telomere-Related Genes and Cancer Risk, 2018-06-12

• A New Clinically Based Staging System for Perihilar Cholangiocarcinoma, 2014-11-11

• VASP promotes TGF-ß activation of hepatic stellate cells by regulating Rab11 dependent plasma membrane targeting of TGF-ß receptors, 2014-09-19

• Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances [version 1; referees: 4 approved], 2016-05-12

• HGT-ID: an efficient and sensitive workflow to detect human-viral insertion sites using next-generation sequencing data, 2018-07-17

• Rationale and design of theHepatocellular carcinoma Early Detection Strategystudy: A multi-center longitudinal initiative of the National Cancer Institute's Early Detection Research Network, 2018-11-12

• The Difference a Decade Makes, 2021-09-15

• Khat chewing and cirrhosis in Somaliland: Case series, 2016-07-28

• Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis, 2014-09-08

• Cirrhosis is Present in Most Patients with Hepatitis B and Hepatocellular Carcinoma, 2010-09-08

• Decreasing trend of serum alpha-fetoprotein level in hepatocellular carcinoma, 2021-08-12

• Aspirin, statins, non-aspirin NSAIDs, metformin and the risk of Biliary Cancer: A Swedish population-based cohort study, 2022-04-01

• Impact of Surveillance for Hepatocellular Carcinoma on Survival in Patients with Compensated Cirrhosis, 2018-05-09

• Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy, 2018-11-04

• Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular Carcinoma, 2016-08-08

• Disparities in curative treatments and outcomes for early-stage intrahepatic cholangiocarcinoma in the United States, 2022-08-23

• Biliary Tract Cancers in Olmsted County, Minnesota, 1976-2008, 2012-07-03

• Hepatic stellate cell-derived PDGFRa-enriched extracellular vesicles promote liver fibrosis in mice through SHP2, 2018-05-10

• Mortality burden due to liver cirrhosis and hepatocellular carcinoma in Ghana; prevalence of risk factors and predictors of poor in-hospital survival, 2022-09-13

• Morphological heterogeneity in beta-catenine-mutated hepatocellular carcinomas:implications for tumor molecular classification, 2021-09-27

• Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma, 2016-02-09

• Identification of fucosylated Fetuin-A as a potential biomarker for cholangiocarcinoma, 2017-07-10

• Racial Disparities in Treatment Initiation and Outcomes of Chronic Hepatitis B Virus Infection in North America Racial Disparities in Treatment and Outcomes of Chronic Hepatitis B Virus Infection, 2023-04-10

• Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group trial N0745 (Alliance), 2017-09-01

• Exome sequencing identifies frequent inactivating mutations inBAP1,ARID1AandPBRM1in intrahepatic cholangiocarcinomas, 2013-11-03

• 4015 Evaluation of the Impact of a Clinical and Translational Science Predoctoral Program on Post-Graduate Outcomes, 2020-06-01

• Hepatitis C virus seroprevalence, testing, and treatment capacity in public health facilities in Ghana, 2016-2021; A multi-centre cross-sectional study, 2023-06-23

• Activation of the TGFß/SMAD Transcriptional Pathway Underlies a Novel Tumor Promoting Role of Sulfatase1 in Hepatocellular Carcinoma*, 2015-02-13

• Exogene: A performant workflow for detecting viral integrations from paired-end next-generation sequencing data, 2021-09-22

• Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and Cholangiocarcinoma, 2022-04-24

• Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation, 2019-02-05

• UNIQUE GENOMIC PROFILE OF FIBROLAMELLAR HEPATOCELLULAR CARCINOMA, 2014-12-31

• Molecular testing for the clinical diagnosis of fibrolamellar carcinoma, 2017-09-01

• Aspirin and Statin Use and the Risk of Gallbladder Cancer, 2021-03-09

• One-Carbon Metabolism-Related Micronutrients Intake and Risk for Hepatocellular Carcinoma: A Prospective Cohort Study, 2020-04-25

• CcnelOverexpression Causes Chromosome Instability in Liver Cells and Liver Tumor Development in Mice, 2019-03-13

• Knowledge, Attitudes, and Behaviors of Viral Hepatitis Among Recent African Immigrants in the United States: A Community Based Participatory Research Qualitative Study, 2020-03-06

• Hepatocellular carcinoma presentation and prognosis among Nigerian adults with and without HIV, 2023-03-06

• SULF2 monoclonal antibody 5D5 suppresses human cholangiocarcinoma xenograft growth via regulation of a SULF2-PDGFRß-YAP signaling axis, 2021-05-24

• The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth, 2023-02-28

• Viral Hepatitis among Somali Immigrants in Minnesota: Association of Hepatitis C with Hepatocellular Carcinoma, 2012-04-20

• BALAD and BALAD-2 Predict Survival of Hepatocellular Carcinoma Patients: a North American Cohort Study, 2020-10-03

• The Transcription Factor GLI1 Mediates TGFß1 Driven EMT in Hepatocellular Carcinoma via a SNAI1-Dependent Mechanism, 2012-11-19

• Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B, 2023-04-18

• Guidelines for Management of Urgent Symptoms in Patients with Cholangiocarcinoma and Biliary Stents or Catheters Using the Modified RAND/UCLA Delphi Process, 2020-08-21

• Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signaling, 2021-02-23

• AS30D Model of Hepatocellular Carcinoma: Tumorigenicity and Preliminary Characterization by Imaging, Histopathology, and Immunohistochemistry, 2012-08-25

• Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma, 2015-10-01

• Distinct phenotype and function of circulating Vd1+and Vd2+?dT-cells in acute and chronic hepatitis B, 2019-04-18

• A nationwide cross-sectional review of in-hospital hepatitis B virus testing and disease burden estimation in Ghana, 2016 - 2021, 2022-11-23

• Short and long telomeres increase risk of amnestic mild cognitive impairment, 2014-10-22

• Association of metabolic health phenotypes, obesity, and hepatocellular carcinoma risk, 2021-12-23

• Model for End-Stage Liver Disease (MELD) Score Measurements on The Daily Basis in Critically Ill Cirrhotic Patients Do Not Provide Additional Prognostic Value, 2015-08-03

• Independent and joint use of statins and metformin by elderly patients with diabetes and overall survival following HCC diagnosis, 2019-01-24

• Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors, 2011-12-13

• Molecular Classification and Therapeutic Targets in Extrahepatic Cholangiocarcinoma, 2020-03-12

• Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States, 2023-01-30

• Using cell-free DNA for HCC surveillance and prognosis, 2021-05-10

• TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis, 2022-08-09

• Novel deleterious dihydropyrimidine dehydrogenase variants may contribute to 5-fluorouracil sensitivity in an East African population, 2016-11-26

• Hedgehog Inhibition Promotes a Switch from Type II to Type I Cell Death Receptor Signaling in Cancer Cells, 2011-03-31

• Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection, 2023-03-01

• DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma, 2019-10-21

• Hypothyroidism is associated with worse outcomes of hepatocellular carcinoma patients after liver transplantation, 2018-11-19

• Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation, 2023-06-19